{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9,
    10,
    11,
    12,
    13,
    14,
    15,
    16,
    17,
    18,
    19,
    20,
    21,
    22,
    23,
    24,
    25,
    26,
    27,
    28,
    29,
    30,
    31,
    32,
    33,
    34,
    35,
    36,
    37,
    38,
    39,
    40,
    41,
    42,
    43,
    44,
    45,
    46,
    47,
    48,
    49
  ],
  "modelUsed": "gemini-3-flash-preview",
  "interventions": {
    "studyInterventions": [
      {
        "id": "int_1",
        "name": "PDR001",
        "type": {
          "id": "c58c1e97-45c4-44d0-9279-05c97ee3193a",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "189722b4-a560-4a0d-8ec4-6fafb68c43f7",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Anti-PD-1 antibody",
        "productIds": [
          "prod_1"
        ],
        "administrationIds": [
          "admin_1"
        ]
      },
      {
        "id": "int_2",
        "name": "Dabrafenib",
        "type": {
          "id": "d72154f6-6e1c-455a-a6e9-e99c5a193d29",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "eb8a040b-a857-4e3a-8de0-b3fbcee9982b",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "BRAF inhibitor",
        "productIds": [
          "prod_2"
        ],
        "administrationIds": [
          "admin_2"
        ]
      },
      {
        "id": "int_3",
        "name": "Trametinib",
        "type": {
          "id": "9ec15d44-5b4a-470d-b64b-e7e3f0598403",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "role": {
          "id": "64b191e3-3758-4c75-8411-d0a562b47c96",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "MEK inhibitor",
        "productIds": [
          "prod_3"
        ]
      },
      {
        "id": "int_4",
        "name": "Placebo",
        "type": {
          "id": "a883fb37-3a21-4431-abb1-acd18fe0e218",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "role": {
          "id": "ab49d78a-5634-4222-addd-99694714e5b1",
          "code": "C41132",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Placebo",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Matching placebo for PDR001"
      },
      {
        "id": "int_5",
        "name": "Corticosteroids",
        "type": {
          "id": "7a14739b-635c-4ba0-916e-907b981885f6",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "ddc2462c-714f-429b-bf95-8aa2533687a6",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Used for management of immune-related adverse events (irAEs) and pyrexia"
      },
      {
        "id": "int_6",
        "name": "RANK-ligand inhibitors",
        "type": {
          "id": "32a4504a-83c4-457b-9985-2a8d5b462a5b",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "706069b3-dc0e-4703-973f-fd963f05af8c",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted bone targeted therapies (e.g., denosumab)"
      },
      {
        "id": "int_7",
        "name": "Bisphosphonates",
        "type": {
          "id": "bae40f1a-006f-495d-b5d9-312ff074fdf0",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "879ad707-e83a-4767-8dc2-9af9a9177e3b",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Permitted concomitant agents"
      },
      {
        "id": "int_8",
        "name": "CYP2C or CYP3A4 substrates",
        "type": {
          "id": "35475e18-7e82-4c51-b67a-84f5252bc2f5",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "role": {
          "id": "baf5bd1d-3dd1-42c9-ab76-c930ce80f56d",
          "code": "C54126",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Concomitant Medication",
          "instanceType": "Code"
        },
        "instanceType": "StudyIntervention",
        "description": "Require caution when co-administered with dabrafenib due to drug-drug interactions"
      }
    ],
    "administrableProducts": [
      {
        "id": "prod_1",
        "name": "PDR001",
        "administrableDoseForm": {
          "id": "30b8dee6-ebc7-4684-8525-99682e7847c2",
          "code": "C42986",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Solution",
          "standardCode": {
            "id": "246e5f8d-a1ee-47a4-b831-8554cbc859cc",
            "code": "C42986",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Solution",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "b0703d47-d541-4b5d-b23a-99de55c383b4",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "substanceIds": [
          "sub_1"
        ],
        "manufacturer": "Novartis"
      },
      {
        "id": "prod_2",
        "name": "Dabrafenib",
        "administrableDoseForm": {
          "id": "59f513cb-b25e-4fe8-a010-12b09a6c4d64",
          "code": "C17998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Unknown",
          "standardCode": {
            "id": "2462d6cd-2ba2-4914-9031-9df7c30a54b8",
            "code": "C17998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Unknown",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "c6c5c1ae-77a7-4394-98ae-5dbc66e1f593",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "substanceIds": [
          "sub_2"
        ],
        "manufacturer": "Novartis"
      },
      {
        "id": "prod_3",
        "name": "Trametinib",
        "administrableDoseForm": {
          "id": "335aa348-34ce-447a-97c5-b20d3f6cba5c",
          "code": "C17998",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Unknown",
          "standardCode": {
            "id": "324fd619-3d4c-4900-b346-b2c8196fc90f",
            "code": "C17998",
            "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
            "codeSystemVersion": "25.01d",
            "decode": "Unknown",
            "instanceType": "Code"
          },
          "instanceType": "Code"
        },
        "productDesignation": {
          "id": "aa5a2dfe-10bf-4704-9599-8f0f919f9b0f",
          "code": "C54121",
          "codeSystem": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl",
          "codeSystemVersion": "25.01d",
          "decode": "Investigational Product",
          "instanceType": "Code"
        },
        "instanceType": "AdministrableProduct",
        "strength": "Not specified",
        "substanceIds": [
          "sub_3"
        ],
        "manufacturer": "Novartis"
      }
    ],
    "administrations": [
      {
        "id": "admin_1",
        "name": "Standard Triplet Regimen",
        "instanceType": "Administration",
        "dose": "PDR001 400 mg, Dabrafenib 150 mg, Trametinib 2 mg",
        "doseFrequency": "PDR001 Q4W, Dabrafenib BID, Trametinib QD",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "id": "admin_2",
        "name": "Safety Run-in Co-administration",
        "instanceType": "Administration",
        "dose": "Dabrafenib 150 mg, Trametinib 2 mg",
        "doseFrequency": "90 minutes after PDR001 completion",
        "route": {
          "code": "Oral",
          "codeSystem": "USDM",
          "decode": "Oral"
        },
        "duration": "Part 1 specific instruction"
      }
    ],
    "substances": [
      {
        "id": "sub_1",
        "name": "PDR001",
        "instanceType": "Substance",
        "description": "Anti-PD-1 monoclonal antibody"
      },
      {
        "id": "sub_2",
        "name": "Dabrafenib",
        "instanceType": "Substance",
        "description": "BRAF inhibitor"
      },
      {
        "id": "sub_3",
        "name": "Trametinib",
        "instanceType": "Substance",
        "description": "MEK inhibitor"
      }
    ],
    "medicalDevices": [],
    "summary": {
      "interventionCount": 8,
      "productCount": 3,
      "deviceCount": 0
    }
  },
  "rawResponse": {
    "interventions": [
      {
        "name": "PDR001",
        "role": "Investigational Product",
        "description": "Anti-PD-1 antibody"
      },
      {
        "name": "Dabrafenib",
        "role": "Investigational Product",
        "description": "BRAF inhibitor"
      },
      {
        "name": "Trametinib",
        "role": "Investigational Product",
        "description": "MEK inhibitor"
      },
      {
        "name": "Placebo",
        "role": "Placebo",
        "description": "Matching placebo for PDR001"
      },
      {
        "name": "Corticosteroids",
        "role": "Concomitant Medication",
        "description": "Used for management of immune-related adverse events (irAEs) and pyrexia"
      },
      {
        "name": "RANK-ligand inhibitors",
        "role": "Concomitant Medication",
        "description": "Permitted bone targeted therapies (e.g., denosumab)"
      },
      {
        "name": "Bisphosphonates",
        "role": "Concomitant Medication",
        "description": "Permitted concomitant agents"
      },
      {
        "name": "CYP2C or CYP3A4 substrates",
        "role": "Concomitant Medication",
        "description": "Require caution when co-administered with dabrafenib due to drug-drug interactions"
      }
    ],
    "products": [
      {
        "name": "PDR001",
        "doseForm": "Powder for solution for infusion",
        "strength": "Not specified",
        "manufacturer": "Novartis"
      },
      {
        "name": "Dabrafenib",
        "doseForm": "Not specified",
        "strength": "Not specified",
        "manufacturer": "Novartis"
      },
      {
        "name": "Trametinib",
        "doseForm": "Not specified",
        "strength": "Not specified",
        "manufacturer": "Novartis"
      }
    ],
    "substances": [
      {
        "name": "PDR001",
        "description": "Anti-PD-1 monoclonal antibody"
      },
      {
        "name": "Dabrafenib",
        "description": "BRAF inhibitor"
      },
      {
        "name": "Trametinib",
        "description": "MEK inhibitor"
      }
    ],
    "administrations": [
      {
        "name": "Standard Triplet Regimen",
        "dose": "PDR001 400 mg, Dabrafenib 150 mg, Trametinib 2 mg",
        "frequency": "PDR001 Q4W, Dabrafenib BID, Trametinib QD",
        "route": "PDR001 IV, Dabrafenib Oral, Trametinib Oral",
        "duration": "Until disease progression or unacceptable toxicity"
      },
      {
        "name": "Safety Run-in Co-administration",
        "dose": "Dabrafenib 150 mg, Trametinib 2 mg",
        "frequency": "90 minutes after PDR001 completion",
        "route": "Oral",
        "duration": "Part 1 specific instruction"
      }
    ],
    "devices": []
  }
}